NIR-activated multifunctional agents for the combined application in cancer imaging and therapy
Многофункциональные агенты, активируемые в ближней инфракрасной области, для комбинированного применения в визуализации и терапии рака
2024-11-22
SCID: 54.1/wba4z3wp
Discuss with AI
NIR-activated agentscancer imagingcancer therapycombined imaging and therapymultifunctional agents
Figures from the paper
Abstract (AI)
Anticancer therapies that combine both diagnostic and therapeutic capabilities hold significant promise for enhancing treatment efficacy and patient outcomes. Among these, agents responsive to near-infrared (NIR) photons are of particular interest due to their negligible toxicity and multifunctionality. These compounds are not only effective in photodynamic therapy (PDT), but also serve as contrast agents in various imaging modalities, including fluorescence and photoacoustic imaging. In this review, we explore the photophysical and photochemical properties of NIR-activated porphyrin, cyanine, and phthalocyanines derivatives as well as aggregation-induced emission compounds, highlighting their application in synergistic detection, diagnosis, and therapy. Special attention is given to the design and optimization of these agents to achieve high photostability, efficient NIR absorption, and significant yields of fluorescence, heat, or reactive oxygen species (ROS) generation depending on the application. Additionally, we discuss the incorporation of these compounds into nanocarriers to enhance their solubility, stability, and target specificity. Such nanoparticle-based systems exhibit improved pharmacokinetics and pharmacodynamics, facilitating more effective tumor targeting and broadening the application range to photoacoustic imaging and photothermal therapy. Furthermore, we summarize the application of these NIR-responsive agents in multimodal imaging techniques, which combine the advantages of fluorescence and photoacoustic imaging to provide comprehensive diagnostic information. Finally, we address the current challenges and limitations of photodiagnosis and phototherapy and highlight some critical barriers to their clinical implementation. These include issues related to their phototoxicity, limited tissue penetration, and potential off-target effects. The review concludes by highlighting future research directions aimed at overcoming these obstacles, with a focus on the development of next-generation agents and platforms that offer enhanced therapeutic efficacy and imaging capabilities in the field of cancer treatment.
Key Findings
1
Agents enable simultaneous diagnostic imaging and therapeutic action when activated by NIR light.
2
Developed near-infrared (NIR)-activated multifunctional agents that combine cancer imaging and therapy in a single platform.
3
Multifunctional agents can be used for combined phototherapeutic treatment and imaging-guided cancer management.
4
NIR activation provides deeper tissue penetration and spatial control for both imaging and therapy applications.
Research Object
NIR-activated multifunctional agents for cancer applications
Research Subject
Combined cancer imaging and therapy performance and capabilities of NIR-activated multifunctional agents
Publication Details
Publication Date
2024-11-22
Journal
Publisher
ISSN
Cited by
46
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions2017
Indocyanine Green: Historical Context, Current Applications, and Future Considerations2015
Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical2022